# OnCo record aromatase-inhibitor (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/aromatase-inhibitor/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "aromatase-inhibitor" ;
  schema:name "Aromatase inhibitor"@en ;
  schema:alternateName "aromatase inhibitors"@en, "aromatase inhibition"@en, "ovarian suppression"@en, "ovarian function suppression"@en, "OFS"@en, "extended endocrine therapy"@en, "adjuvant endocrine therapy"@en, "endocrine therapy"@en ;
  schema:description "Pills that stop the body making oestrogen (after the menopause, when it comes from fat and muscle rather than the ovaries), starving hormone receptor-positive breast cancer. Taken for five to ten years after surgery, they halve recurrence."@en ;
  schema:url <https://onco.cc/terms/aromatase-inhibitor/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Aromatase_inhibitor> ;
  schema:citation <https://en.wikipedia.org/wiki/Aromatase_inhibitor> ;
  onco:related <https://onco.cc/terms/hormone-receptor-status/>, <https://onco.cc/terms/serd/>, <https://onco.cc/terms/endocrine-resistance/>, <https://onco.cc/terms/salpingo-oophorectomy/> ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:sections <https://onco.cc/fronts/hormonal/> ;
  onco:technologies <https://onco.cc/technologies/endocrine-therapy/>, <https://onco.cc/technologies/cdk46-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/letrozole/>, <https://onco.cc/drugs/tamoxifen/> .